Salhi Imed, Bessalah Salma, Snoun Dalila, Khorchani Touhami, Hammadi Mohamed
Livestock and wildlife laboratory, Arid lands Institute, Gabès University, Medenine, Tunisia, Tel: +216 75 633 005, 633 006.
Iran J Biotechnol. 2020 Jan 1;18(1):e2247. doi: 10.30498/IJB.2020.127753.2247. eCollection 2020 Jan.
Diarrhea caused by Escherichia coli is a major cause of morbidity and mortality in young animals. Few treatment options are available, mainly antibiotic therapy increasingly limited by resistance to commonly used drugs.
The aim of this work was to develop immunotherapy based on the use of camel VHH antibody fragments, or nanobodies, to target pathogenic E. coli surface antigens.
We immunized a camel with a killed strain we had previously isolated from a diarrheic camel calf and identified as expressing the F17 fimbriae antigen.
The immunized animal developed an anti-E.coli immune response including heavy-chain antibodies. Lymphocytes from this animal were purified and RNA isolated to create a VHH library by phage display with a size of about 10 individual transformants. Panning on live E. coli cells resulted in the isolation of VHH fragments specific to the cell surface antigens.
The identification of these antigens can lead to the development of new diagnostic and therapeutic tools against diarrhea.
大肠杆菌引起的腹泻是幼龄动物发病和死亡的主要原因。治疗选择很少,主要是抗生素治疗,而常用药物的耐药性日益限制了其应用。
本研究的目的是开发基于使用骆驼VHH抗体片段(即纳米抗体)靶向致病性大肠杆菌表面抗原的免疫疗法。
我们用先前从腹泻骆驼犊中分离出并鉴定为表达F17菌毛抗原的一株灭活菌株免疫一只骆驼。
免疫动物产生了包括重链抗体在内的抗大肠杆菌免疫反应。从该动物中纯化淋巴细胞并分离RNA,通过噬菌体展示创建一个大小约为10个单个转化体的VHH文库。用活的大肠杆菌细胞进行淘选,得到了对细胞表面抗原特异的VHH片段。
这些抗原的鉴定可导致开发针对腹泻的新诊断和治疗工具。